ASX NEWS

CEO Update and Reaffirmation of 2018 Plans and Milestone 29 January, 2018
RSH – Appendix 4C – quarterly 29 January, 2018
Appendix 3X – Initial Director’s Interest Notice 21 December, 2017
Appendix 3X – Initial Director’s Interest Notice 21 December, 2017
Appendix 3Y – Change of Director’s Interest Notices (x2) 21 December, 2017
Appendix 3Z – Final Director’s Interest Notice 21 December, 2017
Confirmation of Release – RSH – Appendix 3B 20 December, 2017
RESULTS OF ANNUAL GENERAL MEETING Dec 15, 2017
2017 AGM – Chairman’s Address Dec 14, 2017
AGM – Change of Venue & Start Time Nov 29, 2017
2017 Notice of Annual General Meeting and Proxy Form Nov 14, 2017
AirSonea Generation 2 Breath Sensor Update Oct 30, 2017
Appendix 4C – quarterly Oct 30, 2017
Extension of Date for Annual General Meeting Oct 26, 2017
RSH – Respiri Receives Notice of Intention Oct 17, 2017
ASX Announcement – Respiri appoints new CEO 16 October, 2017
RESPIRI FEATURED IN SMALL CAPS NEWS WEBSITE
Respiri is starting to catch the attention of investors and the media as it closes in on the launch of its first commercial product. Market news and information site, Small Caps, has featured the company and has interviewed chairman, Leon L’Huillier, about what lies ahead for the company. Click here to read the article.
Alan Kohler speaks with Chairman, Leon L’Huillier about the opportunity for Respiri and its shareholders as it works through the final steps to commercialisation. Click on the link to hear the podcast and see more great stories from Alan Kohler, The Constant Investor.
Listen now
Breath Sensor Partnership with Grey Innovation Commenced September 12, 2017
Appendix 4E & Annual Financial Report (30 June 2017) August 30, 2017
Respiri remains on track for commercialisation August 9, 2017
Commencing the last step to commercialisation July 27, 2017
Appendix 4C – quarterly July 27, 2017
Respiri & ChinaMay 30, 2017
Company Secretary Appointment/ResignationMay 17, 2017
Executive Chair Remuneration Update
May 17, 2017
Appendix 4C – QuarterlyApril 27, 2017
Partner Discussions Encouraging
April 27, 2017
European CE Mark Approval Received Paving the Way for Successful Partnership Discussions
April 12, 2017
Appendix 3B
March 1, 2017
Text and App Messaging for Better Asthma Care
February 28, 2017
Appendix 3B
February 28, 2017
Appendix 3B
February 27, 2017
Respiri Appendix 4D and Interim Financial Report – Dec 2016
February 28, 2017
RSH – Corporate Advisor for Partner Transactions
February 9, 2017
RSH – Dec 16 Appendix 4C – Respiri
January 31, 2017
RSH – RESPIRI COMPLETES CORE SOFTWARE PLATFORM
January 31, 2017
Appendix 3B – Issue of Capital from AGM Resolutions
December 20, 2016
Appendix 3Y – Change of Director’s Interest Notices (x3)
December 20, 2016
Overnight Monitoring Product Accelerated
December 15, 2016
RSH – Results of Respiri 2016 Annual General Meeting
November 22, 2016
RSH – Chairman’s Address to Shareholders
November 22, 2016
Respiri Market Update – November 2016
November 15, 2016
UK Offers Scope for Respiri to Develop Key Partnerships
November 9, 2016
Appendix 3Z – Final Director’s Interest Notices (DH & RBH)
October 26, 2016
Appendix 4C – First Quarter Cash Report – FY2017
October 26, 2016
RSH – Notice of Annual General Meeting/Proxy Form
October 21, 2016
RSH – ANNUAL FINANCIAL REPORT
June 30, 2016
Appendix 4G – Corporate Governance Disclosure Document
August 31, 2016
Respiri’s Continued Leadership in Asthma Monitoring
August 31, 2016
Appendix 4C – 4th Quarter: Quarterly report for entities admitted on the basis of commitments
July 29, 2016
Research Study Confirms AirSonea’s Ability to Reliably Detect Asthma Wheezing
July 25, 2016
Appendix 3Y – Change in Directors Interest Notices (x5)
June 23, 2016
Allotment of Rights Issue Securities & Top 20 Shareholders
June 23, 2016
RESPIRI $4.3M RIGHTS ISSUE CLOSES WITH SUCCESS
June 17, 2016
RSH – Respiri Receives Strong Interest from Asia
June 9, 2016
RESPIRI LIMITED – RIGHTS ISSUE
May 18, 2016
Pro-rata Rights Issue
May 19, 2016
RESPIRI LIMITED – RIGHTS ISSUE
May 18, 2016
Respiri Limited (ASX:RSH) – Cleansing Notice
May 19, 2016
Cleansing Notice – Notice under section 708A(5)(e)
May 19, 2016
Appendix 3B – New Issue Announcement, Application for Quotation of Additional Securities and Agreement
May 19, 2016
Respiri Announces $4.3M Fully Underwritten Rights Issue
May 19, 2016
RSH Appendix 4C Third Quarter (Jan – Mar 2016)
April 28, 2016
RSH – Market Update
February 29, 2016
RSH – Appendix 4D Half Year Report
December 31, 2015
ISN – iSonea Appoints Deloitte Touche Tohmatsu as Company Auditor
November 30, 2015
ISN – 2015 Annual General Meeting – Chairman’s Address
November 26, 2015
ISN – Results of iSonea 2015 Annual General Meeting
November 26, 2015
ISN – Chicago University IRB Approves AirSonea Research Study
November 25, 2015
ISN – iSonea to Exhibit at China Hi-Tech Fair in Shenzhen China
November 5, 2015
ISN – Notice of Annual General Meeting & Explanatory Memorandum
October 23, 2015